February 24, 2011
1 min read
Save

Thorough cleaning of pediatric skin infections more important than antibiotic choice

Chen AE. Pediatrics. 2011;127:e573-e580.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Vigilance and fastidious wound care of drained, uncomplicated pediatric skin and soft tissue infections likely have more effect than choice of antibiotic treatment, researchers have found.

In a randomized controlled trial comparing cephalexin and clindamycin for treatment of uncomplicated pediatric skin and soft tissue infections, 200 patients aged 6 months to 18 years with uncomplicated skin or soft tissue infections were enrolled from September 2006 to May 2009. One hundred patients in each arm were randomly assigned to 7 days of treatment with cephalexin or clindamycin. Primary and secondary outcomes were clinical improvement of wounds at 48 to 72 hours and resolution of wounds at 7 days.

More than two-thirds (69%) of all patients had methicillin-resistant Staphylococcus aureus cultured from their wounds. Most MRSA were clindamycin-susceptible, consistent with community-associated MRSA. Spontaneous drainage occurred or incision and drainage was performed in 97% of patients. By 48 to 72 hours, 94% of patients in the cephalexin arm and 97% in the clindamycin arm experienced improvement (P=.50). By 7 days, all patients’ wounds had improved, with 97% in the cephalexin group experiencing complete resolution and 94% in the clindamycin arm (P=.33).

Researchers found no association between gender, size of erythema or induration, location of infection, or type of drainage with the primary outcome. Fever and age of younger than 1 year, but not with initial erythema of more than 5 cm, were considered early-treatment failures, regardless of antibiotic used.

“Until additional studies confirm that adjuvant antibiotics offer no benefit in the management of children with uncomplicated, purulent [skin and soft tissue infections], cephalexin remains a viable empiric antibiotic choice (even in areas with a high prevalence of CA-MRSA) in the context of management that already includes careful drainage of purulent collections, attention to wound care, and appropriate follow-up, especially in children of younger age and with fever,” researchers wrote.

Twitter Follow the PediatricSuperSite.com on Twitter.